FIELD: medicine; biotechnology.
SUBSTANCE: group of inventions relates to biotechnology and medicine, namely to technology for implantable medical devices (stents), containing radiopaque substances based on organic compounds of lanthanum distributed in their coverage. Disclosed is a composite material comprising a foundation and glikolan, such as the composition of polyvinyl alcohol and chitosan or polylactic acid.
EFFECT: group of inventions provides satisfactory radiopacity not only during the stenting procedure to the patient, but also after installation, and simultaneously provides additional positive effect due to the therapeutic properties of glikolan.
2 cl, 2 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
| STENT | 2007 |
|
RU2432183C9 |
| GEL COMPOSITION FOR RADIATION THERAPY UNDER VISUAL CONTROL | 2014 |
|
RU2703303C2 |
| STAND FOR EXPANSION OF APERTURE INSIDE THE CANAL BODY | 1994 |
|
RU2180844C2 |
| INTRAOCULAR SYSTEMS OF SUSTAINED-RELEASE DRUG DELIVERY AND METHOD OF TREATING OPHTHALMIC DISEASES | 2010 |
|
RU2532333C2 |
| COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATORY DISEASES | 1997 |
|
RU2242974C2 |
| BIODEGRADABLE ENDOVASCULAR STENT WITH SHAPE MEMORY AND METHOD OF PRODUCTION THEREOF | 2018 |
|
RU2731318C1 |
| BIOCOMPATIBLE PRODUCTS FOR MAGNETIC PARTICLE VISUALISATION | 2009 |
|
RU2496525C2 |
| METHODS AND COMPOSITIONS CONTAINING CLONIDINE, APPLICABLE FOR TREATING POSTOPERATIVE PAIN | 2009 |
|
RU2510263C2 |
| COMPOSITIONS INHIBITING THE DEVELOPMENT OF BLOOD VESSELS AND METHOD FOR THEIR APPLICATIONS | 2001 |
|
RU2304433C2 |
